04 May 2021 - 13:55
FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Reuters
The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and German partner BioNTech SE s COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday, citing federal officials familiar with the agency s plans.
An approval is highly anticipated after the drugmakers said in March that the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year-olds in a clinical trial.
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that they have submitted a request to expand conditional marketing authorization or CMA of their Covid vaccine
(1)
Marimekko Corporation, Inside Information 18 February 2021 at 7.45 a.m.
Marimekko s Board of Directors has decided that a dividend of EUR 0.90 per share will be paid for 2019, and proposes that the AGM authorize the Board to decide on a maximum dividend of EUR 1.00 per share for 2020 at a later stage Pursuant to the authorization granted by the 2020 Annual General Meeting, the Board of Directors of Marimekko has decided that a dividend of EUR 0.90 per share be paid for the financial year 1 January-31 December 2019. The dividend will be paid in one instalment to shareholders who are registered on the dividend payout record date of 22 February 2021 in the company s Shareholder Register held by Euroclear Finland Ltd on behalf of the Board of Directors of Marimekko Corporation. The dividend payout date is 1 March 2021.